Correlation Between Rigel Pharmaceuticals and Cidara Therapeutics
Can any of the company-specific risk be diversified away by investing in both Rigel Pharmaceuticals and Cidara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rigel Pharmaceuticals and Cidara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rigel Pharmaceuticals and Cidara Therapeutics, you can compare the effects of market volatilities on Rigel Pharmaceuticals and Cidara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rigel Pharmaceuticals with a short position of Cidara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rigel Pharmaceuticals and Cidara Therapeutics.
Diversification Opportunities for Rigel Pharmaceuticals and Cidara Therapeutics
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Rigel and Cidara is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and Cidara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cidara Therapeutics and Rigel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rigel Pharmaceuticals are associated (or correlated) with Cidara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cidara Therapeutics has no effect on the direction of Rigel Pharmaceuticals i.e., Rigel Pharmaceuticals and Cidara Therapeutics go up and down completely randomly.
Pair Corralation between Rigel Pharmaceuticals and Cidara Therapeutics
Given the investment horizon of 90 days Rigel Pharmaceuticals is expected to generate 1.14 times more return on investment than Cidara Therapeutics. However, Rigel Pharmaceuticals is 1.14 times more volatile than Cidara Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Cidara Therapeutics is currently generating about 0.05 per unit of risk. If you would invest 1,450 in Rigel Pharmaceuticals on August 25, 2024 and sell it today you would earn a total of 1,154 from holding Rigel Pharmaceuticals or generate 79.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rigel Pharmaceuticals vs. Cidara Therapeutics
Performance |
| Timeline |
| Rigel Pharmaceuticals |
| Cidara Therapeutics |
Rigel Pharmaceuticals and Cidara Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rigel Pharmaceuticals and Cidara Therapeutics
The main advantage of trading using opposite Rigel Pharmaceuticals and Cidara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rigel Pharmaceuticals position performs unexpectedly, Cidara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cidara Therapeutics will offset losses from the drop in Cidara Therapeutics' long position.| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
| Cidara Therapeutics vs. CytomX Therapeutics | Cidara Therapeutics vs. Clearside Biomedical | Cidara Therapeutics vs. GlycoMimetics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |